Health Topics – Johns Hopkins Medicine Podcasts
Jul 3, 2026 · 1 min · 3 segments
For some types of cancer obesity is clearly a risk factor. Now a new study shows that when people with obesity take a GLP-1 agonist to lose weight, they also reduce their risk for these cancers…
Elizabeth TracyThey looked at those who used the GLP-1 receptor agonist and fulfilled at least two prescriptions to compare against people who were formally recommended to undergo diet and exercise.
What they found was a 41% reduction overall in the risk for cancer, myeloma, pancreatic cancer, endometrial cancer, that's cancer of the uterus, colorectal cancer, and thyroid cancer.
and more evidence hinting that if you can treat obesity effectively, it may reduce the risk of cancers that seem to be increased.
They looked at those who used the GLP-1 receptor agonist and fulfilled at least two prescriptions to compare against people who were formally recommended to undergo diet and exercise.
What they found was a 41% reduction overall in the risk for cancer, myeloma, pancreatic cancer, endometrial cancer, that's cancer of the uterus, colorectal cancer, and thyroid cancer.
and more evidence hinting that if you can treat obesity effectively, it may reduce the risk of cancers that seem to be increased.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.
